TP53 and laryngotracheoesophageal cleft: As a result, the identified hubs were AKT1, AR, EGFR, ESR1, JUN, PIK3R1, SRC, TP53, and VEGFA (Figure 3), which suggests that they were the primary nodes mediating the therapeutic roles of FDY003 in LC.